Alexion to acquire Achillion to strengthen rare diseases portfolio

Alexion acquisition of Achillion : Alexion Pharmaceuticals has agreed to acquire rival US pharma company Achillion Pharmaceuticals for about $930 million in an all-cash deal as per the latest pharma acquisition news. Achillion is a clinical-stage biopharma company, which is engaged in developing oral small molecule Factor D inhibitors for the treatment More...

by pharmanewsdaily | Published 8 hours ago
By pharmanewsdaily On Wednesday, October 16th, 2019
0 Comments

Denovo Biopharma gets FDA approval to launch phase 2b GBM trial for DB102

Denovo Biopharma has secured approval from the US Food and Drug Administration (FDA) to launch its phase 2b clinical trial of DB102 in patients with newly-diagnosed glioblastoma (GBM) in combination with radiation More...

By pharmanewsdaily On Tuesday, October 15th, 2019
0 Comments

DAZZLE clinical trial : Kodiak Sciences doses first patients with KSI-301 in phase 3 wet AMD trial

Kodiak Sciences said that it has treated the first patients in the phase 2 DAZZLE clinical trial of KSI-301, its investigational intravitreal anti-VEGF antibody biopolymer conjugate, in wet age-related macular degeneration More...

By pharmanewsdaily On Monday, October 14th, 2019
0 Comments

Kangpu wraps up phase 1 clinical trial of CRL4-CRBN modulator KPG-818

Chinese pharma company Kangpu Biopharmaceuticals said that it has wrapped up the first-in-human phase 1 clinical trial of CRL4-CRBN modulator KPG-818 in the US. KPG-818 is being developed for the treatment of systemic More...

By pharmanewsdaily On Monday, October 14th, 2019
0 Comments

Radioisotopes manufacturer SHINE Medical Technologies creates pharma unit

US radioisotopes manufacturer SHINE Medical Technologies has formed a new business division called SHINE Therapeutics in a move to boost its ability to focus on addressing critical future needs in the therapeutic More...

By pharmanewsdaily On Sunday, October 13th, 2019
0 Comments

Agilent Technologies opens molecular spectroscopy hub in Oxfordshire

Agilent Technologies has opened a new facility for the research and development of molecular spectroscopy at the Harwell Science and Innovation Campus in Oxfordshire, UK. Expected to be a major research and development More...

By pharmanewsdaily On Sunday, October 13th, 2019
0 Comments

Agilent acquires BioTek Instruments for $1.16bn

Agilent acquisition of BioTek : US-based lab instrument manufacturer Agilent Technologies has wrapped up its previously announced $1.16 billion acquisition of life science instrumentation manufacturer BioTek Instruments. The More...

By pharmanewsdaily On Sunday, October 13th, 2019
0 Comments

Alcon launches PanOptix trifocal intraocular lens for cataract patients in US

Alcon has commercially launched AcrySof IQ PanOptix trifocal intraocular lens (IOL) in the US after its approval by the US Food and Drug Administration (FDA). PanOptix is said to be the first trifocal lens to be More...

By pharmanewsdaily On Sunday, October 13th, 2019
0 Comments

CMAB Biopharma, BJ Bioscience join forces for bi-functional antibody BJ-005

CMAB Biopharma (Suzhou), a pure-play biologics CDMO, and BJ Bioscience have signed an agreement for the development and manufacturing of a bi-functional antibody called BJ-005 as the first initiative in an exclusive More...

By pharmanewsdaily On Sunday, October 13th, 2019
0 Comments

Lilly bags Reyvow FDA approval for acute treatment of migraine

Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug Administration (FDA) for Reyvow (lasmiditan) for the acute treatment of migraine, irrespective of aura (a sensory More...